Aktie 726692 ONCOTHERAPY SCIENCE, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen OncoTherapy Science, Inc.

Aktien

726692

JP3202150003

4564

Markt geschlossen - Japan Exchange
Andere Börsenplätze
 08:00:00 17.05.2024 		% 5 Tage % 1. Jan.
15 JPY 0,00 % Intraday Chart für OncoTherapy Science, Inc. -6,25 % -34,78 %
29.04. Polens Tusk ruft Staatsanwalt wegen möglichem Orlen-Skandal an RE
2023 OncoTherapy Science, Inc. meldet Ergebnis für das am 31. März 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Triple Negative Breast Cancer Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)
Poland's Tusk calls prosecutor over potential Orlen scandal
OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024
OncoTherapy Science, Inc. announced that it expects to receive ¥3.78 million in funding from Long Corridor Asset Management Limited and another investor
Triple Negative Breast Cancer Pipeline, FDA Approvals, Clinical Trials Assessment, Companies 2023 | Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., and others.
OncoTherapy Science, Inc.(TSE:4564) dropped from S&P Global BMI Index
OncoTherapy Science, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
OncoTherapy Science, Inc. announced that it has received ¥95.95 million in funding
OncoTherapy Science, Inc. announced that it expects to receive ¥95.95 million in funding
OncoTherapy Science : Announcement of the Presentation of Interim Results for Phase I Clinical Study of a Combination of OTSGC-A24 and Immune Checkpoint Inhibitor in Patients with Gastric Cancer
OncoTherapy Science, Inc. announced that it has received ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm
OncoTherapy Science, Inc. announced that it expects to receive ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm
OncoTherapy Science : Japanese bio-venture starts development of COVID-19 peptide vaccine
OncoTherapy Science, Inc. announced that it has received ¥12.013 million in funding from Daiwa Securities Group Inc.
OncoTherapy Science, Inc. announced that it expects to receive ¥12.013 million in funding from Daiwa Securities Group Inc.
Oncotherapy Science, Inc. and Theragen Etex Co.,Ltd., to Form Joint Venture Company
OncoTherapy Science, Inc.(TSE:4564) added to Russell Global Index
OncoTherapy Science, Inc. Signs Licensing Agreement with Societe d'Exploitation de Produits pour les Industries Chimiques S.A
Shionogi & Co. Signs Agreement with OncoTherapy Science Inc. for Cancer Peptide Vaccines
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 726692 Aktie
  4. Nachrichten OncoTherapy Science, Inc.
  5. Andere Sprachen